The herpes simplex virus 1 U(L)34 protein interacts with a cytoplasmic dynein intermediate chain and targets nuclear membrane.
about
ICP0 dismantles microtubule networks in herpes simplex virus-infected cellsRole of dynein, dynactin, and CLIP-170 interactions in LIS1 kinetochore functionConformational changes in the nuclear lamina induced by herpes simplex virus type 1 require genes U(L)31 and U(L)34Interaction of the rabies virus P protein with the LC8 dynein light chainCoupling viruses to dynein and kinesin-1Microtubule plus end-associated CLIP-170 initiates HSV-1 retrograde transport in primary human cellsRotavirus viroplasm fusion and perinuclear localization are dynamic processes requiring stabilized microtubulesMultivalency in the Assembly of Intrinsically Disordered Dynein Intermediate ChainInteraction of HCF-1 with a cellular nuclear export factorHerpes simplex virus type 1 capsid protein VP26 interacts with dynein light chains RP3 and Tctex1 and plays a role in retrograde cellular transportCytoplasmic dynein mediates adenovirus binding to microtubules.Function of dynein and dynactin in herpes simplex virus capsid transport.The pseudorabies virus VP1/2 tegument protein is required for intracellular capsid transportNuclear localization signal peptides induce molecular delivery along microtubules.Reconstitution of herpes simplex virus microtubule-dependent trafficking in vitro.The Herpesvirus capsid surface protein, VP26, and the majority of the tegument proteins are dispensable for capsid transport toward the nucleus.Adenovirus transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunitLocal modulation of plus-end transport targets herpesvirus entry and egress in sensory axonsTargeting of herpesvirus capsid transport in axons is coupled to association with specific sets of tegument proteins.Recognition of novel viral sequences that associate with the dynein light chain LC8 identified through a pepscan technique.The interacting UL31 and UL34 gene products of pseudorabies virus are involved in egress from the host-cell nucleus and represent components of primary enveloped but not mature virions.Effects of charged cluster mutations on the function of herpes simplex virus type 1 UL34 protein.Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus.Identification of an essential domain in the herpes simplex virus 1 UL34 protein that is necessary and sufficient to interact with UL31 protein.Herpes simplex virus 1 ICP22 regulates the accumulation of a shorter mRNA and of a truncated US3 protein kinase that exhibits altered functionsRNAs extracted from herpes simplex virus 1 virions: apparent selectivity of viral but not cellular RNAs packaged in virions.U(L)31 and U(L)34 proteins of herpes simplex virus type 1 form a complex that accumulates at the nuclear rim and is required for envelopment of nucleocapsidsThe association of viral proteins with host cell dynein components during virus infection.The crystal structure of dynein intermediate chain-light chain roadblock complex gives new insights into dynein assemblySorting and transport of alpha herpesviruses in axons.Herpes simplex virus tegument protein US11 interacts with conventional kinesin heavy chain.Rapid directional translocations in virus replication.Roles for herpes simplex virus type 1 UL34 and US3 proteins in disrupting the nuclear lamina during herpes simplex virus type 1 egress.Baculovirus as versatile vectors for protein expression in insect and mammalian cells.Light chain-dependent self-association of dynein intermediate chain.An endoplasmic reticulum protein, p180, is highly expressed in human cytomegalovirus-permissive cells and interacts with the tegument protein encoded by UL48Update on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective.Reconstitution of the Kaposi's sarcoma-associated herpesvirus nuclear egress complex and formation of nuclear membrane vesicles by coexpression of ORF67 and ORF69 gene products.Emerin is hyperphosphorylated and redistributed in herpes simplex virus type 1-infected cells in a manner dependent on both UL34 and US3.HSV trafficking and development of gene therapy vectors with applications in the nervous system.
P2860
Q21136348-40065C91-C4CD-4A63-9E26-AA0A8DFA29EBQ24292442-CFC01087-72B5-4429-AA37-B4EF3FA4C23CQ24292954-216A8635-16AD-4FB0-8A49-7EC454B2291DQ24515070-89E0C552-E561-4805-A3F9-649461D5B78CQ26864993-04F84233-626A-4D49-8FC6-C87EA5183E47Q27309233-F2057A75-0F98-4529-8ED4-E8EF6B2DAE25Q27313339-1F4A881F-06ED-416D-9192-77F4D10A6E62Q27657450-1F7BD1D6-41BD-4AB3-8E28-DD651D5C408FQ28202182-CF82F4C7-0E9A-4F24-A40E-E0DD2B41FD94Q28259269-AEC271FF-6040-4ACA-AD2C-D26DCC522DD8Q30448880-9C0C4C46-6597-471B-82D7-615A3A6FC626Q30453354-21C44533-2813-4A40-A317-11CEBE6C1E3CQ30476546-940F1393-7032-4709-B38B-E3512EA92FADQ30476771-90B9662A-A9C7-4136-9DC8-9109F05B8A4FQ30477354-A7111A4E-256C-4CD8-A424-E0AEA7865F82Q30477358-105E670A-0F89-441A-A6D8-D810046021F7Q30492884-7AD7D880-3F4E-4F20-B997-7926CA8649A1Q30837157-1F8421FC-C164-4BCF-AC33-25288B475EE4Q30856858-2B6A53F9-278F-4F34-8357-F0D53878D816Q30940942-C7DF7636-656D-40CB-A9DB-E28BA5991828Q31032273-71312880-DF64-4733-A6C1-F9C5D563D363Q31146166-7D0D1EBB-54C0-4FF9-9F55-65028B692B40Q31156919-DB0AEA2E-7765-4C4D-B404-53BD3D44FADCQ33737760-B8C05F98-BFD2-4C49-B9BD-61B20444623EQ33843248-172EF560-1A10-42BB-B2D8-29298C138C48Q33853688-FB0A0977-617D-4D65-8060-1643DB8CC735Q33854765-FE41E735-0364-4ADD-B1FD-B518BE550BC4Q33967271-E3AF53D0-CA2D-4250-B96C-A4D3C23B3D84Q33991122-3F281338-3459-4B55-847C-2452AE2783A8Q34291839-3B2974C9-D375-4F0A-9909-80E7513E936DQ34333855-F89E1485-2C56-432D-B3E1-03042FA8076FQ34338075-0C17BD5B-D0C1-48EC-8B5D-58F8B935783CQ34357194-B88C809B-39EF-4BDD-B141-647F944B70A9Q34416430-5289DFFD-AF48-41C3-B351-72C249AC66ABQ34489101-F904BBDD-AFF9-4487-91F5-CE537594BD2AQ34971117-C34EB970-AFAB-4C0C-BD42-8B0518F38DC6Q35531731-DF0AFBF9-0468-4076-957F-914865D7BA98Q35665989-67607936-20A4-4657-BFA5-23A00E2148C9Q36099092-98889AF5-9F37-4397-A008-40CF406B3313Q36134871-35EBF0BB-3384-4E96-882A-86FD03879E09
P2860
The herpes simplex virus 1 U(L)34 protein interacts with a cytoplasmic dynein intermediate chain and targets nuclear membrane.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The herpes simplex virus 1 U(L ...... and targets nuclear membrane.
@ast
The herpes simplex virus 1 U(L ...... and targets nuclear membrane.
@en
type
label
The herpes simplex virus 1 U(L ...... and targets nuclear membrane.
@ast
The herpes simplex virus 1 U(L ...... and targets nuclear membrane.
@en
prefLabel
The herpes simplex virus 1 U(L ...... and targets nuclear membrane.
@ast
The herpes simplex virus 1 U(L ...... and targets nuclear membrane.
@en
P2093
P2860
P1433
P1476
The herpes simplex virus 1 U(L ...... and targets nuclear membrane.
@en
P2093
P2860
P304
P356
10.1128/JVI.74.3.1355-1363.2000
P577
2000-02-01T00:00:00Z